AlphaStocks
5.9
Consider Buy

Schrodinger, Inc. (SDGR)

As of Sep 20, 2026, Schrodinger, Inc. (SDGR) scores 5.9/10 on AlphaStocks' five-model composite, #55 of 168 Health Care stocks.

Health Care / Health Care Services

S&P SmallCap 600

$29.01

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 3 of 5 models — moderate confidence

Data as of Sep 20, 2026

#55out of 168 in Health Care

Is Schrodinger, Inc. a Good Investment in 2026?

Schrodinger, Inc. (SDGR) scores 5.9 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model is the most favorable, rating Schrodinger, Inc. as Neutral. However, the Buffett model rates it Caution. Schrodinger, Inc. ranks #55 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-10.5Market Cap2B

Valuation

Currently unprofitable — fair value estimate not available.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Schrodinger, Inc. (SDGR) a good investment?
As of Sep 20, 2026, Schrodinger, Inc. (SDGR) scores 5.9/10 on AlphaStocks' five-model composite, #55 of 168 Health Care stocks. That is a middle-of-the-pack score with no strong signal either way. Currently unprofitable — fair value estimate not available.
What is Schrodinger, Inc.'s Piotroski F-Score?
Schrodinger, Inc.'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is SDGR overvalued or undervalued?
A precise fair value estimate is not available for SDGR. Currently unprofitable — fair value estimate not available.
How does SDGR compare to other Health Care stocks?
Schrodinger, Inc. ranks #55 out of 168 stocks in the Health Care sector, placing it in the top 33% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about SDGR?
AlphaStocks evaluates SDGR using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Neutral. These models are combined into a single composite score of 5.9/10.

Similar Stocks

DVAMDDGX

Compare SDGR with

DVA vs SDGRMD vs SDGRDGX vs SDGRSDGR vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer